Skip to main content

Closed

SLXN: Silexion Therapeutics Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC1448.8%

Financially safe

Strong

Debt / equity1.50×

Interest coverage1755.5×

Current ratio1.00×

Valuation

Unrated

P/E ratio0.0×

Silexion Therapeutics Ltd.

SLXNNASDAQ Global Market·USD·Closed

Silexion Therapeutics Ltd.

SLXNNASDAQ·USD·Closed

$1.88

+2.17%

$1.88

+$0.04 (2.17%)

52W Range

0thpctl

Volume

0.14×avg

Mkt Cap

787712USD

P/E

0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.14×avg

Market Cap

787712USD

P/E Ratio

0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings